Your browser doesn't support javascript.
loading
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development.
Donaldson, Joshua M; Seddiq, Marjilla; Fusco, Michael J; Singla, Shyamli; Pamuk, Gulsum E; Lee-Alonso, Rosa J; Mixter, Bronwyn D; Goldberg, Kirsten B; Amiri-Kordestani, Laleh; de Claro, R Angelo; Drezner, Nicole; Gormley, Nicole J; Kanapuru, Bindu; Lemery, Steven J; Fashoyin-Aje, Lola A; Richardson, Nicholas C; Singh, Harpreet; Suzman, Daniel L; Theoret, Marc R; Kluetz, Paul G; Pazdur, Richard.
Afiliación
  • Donaldson JM; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Seddiq M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Fusco MJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Singla S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Pamuk GE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Lee-Alonso RJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Mixter BD; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Goldberg KB; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • de Claro RA; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Drezner N; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Gormley NJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Kanapuru B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Lemery SJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Fashoyin-Aje LA; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Richardson NC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Singh H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Suzman DL; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Theoret MR; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Kluetz PG; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Cancer Discov ; 13(12): 2515-2524, 2023 12 12.
Article en En | MEDLINE | ID: mdl-38084090
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Child / Humans País/Región como asunto: America do norte Idioma: En Revista: Cancer Discov Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Child / Humans País/Región como asunto: America do norte Idioma: En Revista: Cancer Discov Año: 2023 Tipo del documento: Article